Clinical Trials Directory

Trials / Completed

CompletedNCT03938753

Quality Control of CE-Certified Phonak Hearing Aids - 2018_42

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Sonova AG · Industry
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Phonak Hearing Systems pass through different development and study stages. At an early stage, feasibility studies are conducted to investigate new algorithms, features and functions in an isolated manner. If the benefit is proven, their performance is then investigated regarding interdependency between all available algorithms, features and functions running in parallel in a hearing aid (pivotal/pre-validation studies) and, as a result, they get optimized. Afterwards, and prior to product launch, the Phonak Hearing Systems undergo a final quality control in terms of clinical trials. This is a pre-validation study, investigating optimized algorithms, features, functions and wearing comfort. This will be a clinical evaluation which will be conducted mono centric at Sonova AG Headquarters based in Stäfa (Switzerland).

Detailed description

In this study one CE-labeled Phonak Receiver-in-the-canal (RIC) devices is investigated. The experimental device will be investigated regarding Sound Quality perception ot the T-Coil program. A secondary objective of this study is the investigation of the Overall system stability in daily life situations. The experimental device contains direct connectivity functionality and a T-Coil. The combination of a wireless chip for Bluetooth streaming and a T-Coil in one housing can cause audible artifacts on the T-Coil, which shall be investigated within this study. This will be a clinical evaluation which will be conducted mono centric at Sonova AG Headquarters based in Stäfa (Switzerland).

Conditions

Interventions

TypeNameDescription
DEVICEAudéo M90-TReceiver in the canal (RIC) Hearing aid form Phonak which will be fitted to the participants individual Hearing loss.

Timeline

Start date
2019-01-09
Primary completion
2019-02-07
Completion
2019-02-28
First posted
2019-05-06
Last updated
2019-05-06

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03938753. Inclusion in this directory is not an endorsement.